<?xml version="1.0" encoding="UTF-8"?>
<p id="Par60">The onset of meningoencephalitis usually occurs 1 to 4 weeks after the first symptoms (which may be very mild or subclinical), and in some cases neurological complications can manifest beyond 60 days after the initial symptoms of RVF. Clinical features may include intense headache, neurological deficit, rigor, neck rigidity, hyperreflexia, hypersalivation, choreiform movements, loss of memory, hallucinations, confusion, disorientation, vertigo, convulsions, ataxia, lethargy, decerebrate posturing, locked-in syndrome and coma [
 <xref ref-type="bibr" rid="CR17">17</xref>, 
 <xref ref-type="bibr" rid="CR35">35</xref>, 
 <xref ref-type="bibr" rid="CR44">44</xref>, 
 <xref ref-type="bibr" rid="CR70">70</xref>–
 <xref ref-type="bibr" rid="CR73">73</xref>]. In a human outbreak in Mauritania in 1989, up to 5% of observed infections had encephalitis [
 <xref ref-type="bibr" rid="CR71">71</xref>]. Two types of pure encephalitis were described: acute febrile forms with short duration and possibility of death, and subacute forms with a longer duration, a lower fatality rate but frequent sequelae [
 <xref ref-type="bibr" rid="CR71">71</xref>]. Pulmonary complications may occur [
 <xref ref-type="bibr" rid="CR71">71</xref>, 
 <xref ref-type="bibr" rid="CR74">74</xref>], and malaria can worsen the severity of neurologic symptoms [
 <xref ref-type="bibr" rid="CR19">19</xref>]. Lethality may be as high as 50% in this form [
 <xref ref-type="bibr" rid="CR40">40</xref>].
</p>
